HIV prevention study for African immigrants
Part of Infections, Women’s health & pregnancy clinical trials.
This study looks at how social connections and moving to the U.S. affect HIV prevention for African immigrants. It may help develop better ways to support your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You were born in an African country and now live in the U.S.
- You currently live in New York or Massachusetts.
- You can communicate in English at a basic level (about 3rd-grade reading level).
- You have access to a smartphone or computer with internet for Zoom or WhatsApp.
- You are willing to provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help Black men in NYC who have sex with men access HIV testing and prevention pills. Your participation could help make HIV prevention easier to get for you and your community.
This study tests a personalized care coordination program to help Black men who have sex with men stay on HIV prevention. It focuses on men who are new to or have stopped PrEP and want to reduce their HIV risk.
This study looks at whether getting support from friends and peers who also use drugs can help people start HIV prevention (PrEP) and treatment for substance use. The goal is to make it easier for people who inject drugs to get the care they need.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This study aims to help prevent HIV in Black communities in Miami by using local gathering places like barbershops and salons. You may join if you visit these spots during study events and haven't already taken part before.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.